Consistently, studies in a humanized mouse model of lung cancer showed that IL-34-producing chemoresistant tumors exhibit increased numbers of M2-type TAMs and reduced frequencies of tumor-infiltrating cytotoxic CD8+ T cells [67]. This evidence concerns the gene IL34 and lung carcinoma.